News
15h
allAfrica.com on MSNSA gets R520m to buy the twice-a-year anti-HIV jab... but there’s a snagSouth Africa has accepted an offer of just over $29 million (about R520 million) from the Global Fund to Fight Aids, TB and ...
COVID-19 cases are on the rise again across the United States, with the biggest increases in parts of the South, Southeast ...
COVID-19 cases are on the rise again across the United States, with the biggest increases in parts of the South, Southeast ...
1d
HealthDay on MSNCDC Says COVID-19 Cases Are Rising in 25 StatesCOVID-19 cases are on the rise again across the United States, with the biggest increases in parts of the South, Southeast, and West Coast.
Cases of COVID-19 are now likely growing in 25 states, according to estimates published by the Centers for Disease Control ...
6don MSNOpinion
In Kevin Hassett, the Trump administration has picked an especially unfortunate spokesperson.
1d
Pharmaceutical Technology on MSNWHO endorses Gilead’s Yeztugo for HIV preventionWHO’s director general described the policy guidelines for Gilead’s twice-yearly drug as the “next best thing” in the absence of a vaccine.
Dysregulated myelopoiesis is identified as a driver of nutritionally acquired immunodeficiency that persists after refeeding and nutritional recovery, indicating exposure to food scarcity may be an ...
CRISPR construct to genetically ablate the GABA transporter GAT3 in the mouse visual cortex, with effects on population-level neuronal activity. This work is important, as it sheds light on how GAT3 ...
DelveInsight’s, “Oncolytic Virus Cancer Therapy Pipeline Insight, 2025,” report provides comprehensive insights about 120+ ...
Request To Download Free Sample of This Strategic Report @ Introduction: The agricultural sector in Saudi Arabia is experiencing a significant shift towards sustainable and environmentally friendly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results